Skip to content
Home
Vision
About Us
Our Company
Our CEO
Who We Work With
How Collaboration Actually Starts
Imprint & Privacy Policy
AI Audit Systems
AI Governance
CATALYSE Framework
GOVERN framework for agentic AI
SHAPE Framework
Clinical Trial Innovation
Next Generation Clinical Trials
Fully Individualized Trial Endpoints (FIEPs)
Human–AI Hybrids
Roger Chat
Hybrid Intelligence
Whitepapers & Downloads
Services
News
Contact & Collaboration
Contact
Open Positions
aeschbacher.ai
Home
Vision
About Us
Our Company
Our CEO
Who We Work With
How Collaboration Actually Starts
Imprint & Privacy Policy
AI Audit Systems
AI Governance
CATALYSE Framework
GOVERN framework for agentic AI
SHAPE Framework
Clinical Trial Innovation
Next Generation Clinical Trials
Fully Individualized Trial Endpoints (FIEPs)
Human–AI Hybrids
Roger Chat
Hybrid Intelligence
Whitepapers & Downloads
Services
News
Contact & Collaboration
Contact
Open Positions
aeschbacher.ai
Home
Vision
About Us
Our Company
Our CEO
Who We Work With
How Collaboration Actually Starts
Imprint & Privacy Policy
AI Audit Systems
AI Governance
CATALYSE Framework
GOVERN framework for agentic AI
SHAPE Framework
Clinical Trial Innovation
Next Generation Clinical Trials
Fully Individualized Trial Endpoints (FIEPs)
Human–AI Hybrids
Roger Chat
Hybrid Intelligence
Whitepapers & Downloads
Services
News
Contact & Collaboration
Contact
Open Positions
The Future of Clinical Trials: Fully Individualized Endpoints through Human-AI co-design
By
Roger Aeschbacher
/
January 29, 2026
The Future of Clinical Trials: Fully Individualized Endpoints through Human-AI co-design
Preview: The Future of Clinical Trials – Fully Individualized Endpoints through Human-AI co-design
→